Cargando…
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial
BACKGROUND: Replacement of carmustine (BCNU) in the BEAM regimen (BCNU, etoposide, cytarabine, melphalan) with bendamustine (BendaEAM) before autologous stem cell transplantation (ASCT) is feasible in lymphoma. However, randomised trials are lacking. Here, we present the first trial addressing this...
Autores principales: | Keil, Felix, Müller, Antonia M.S., Berghold, Andrea, Riedl, Regina, Buxhofer-Ausch, Veronika, Schuster, Judith, Vorburger, Corinne, Böhm, Alexandra, Panny, Michael, Nösslinger, Thomas, Greil, Richard, Samaras, Panagiotis, Bencker, Celine, Rütti, Markus, Pabst, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679477/ https://www.ncbi.nlm.nih.gov/pubmed/38024477 http://dx.doi.org/10.1016/j.eclinm.2023.102318 |
Ejemplares similares
-
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma
por: Huwyler, Fabrizio, et al.
Publicado: (2023) -
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study
por: Stoffel, Tanja, et al.
Publicado: (2022) -
Julien Benda
por: Niess, Robert Judson
Publicado: (1956) -
EAM Store Kiosk & EAM light
por: Bennett, Sophia Elizabeth
Publicado: (2017) -
Hadron-fit physics with BEBS at the SPS
por: Grant, A
Publicado: (1972)